Device type · OOI
Real Time Nucleic Acid Amplification System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OOI
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
516
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Real Time Nucleic Acid Amplification System
- Product code
- OOI
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.2570
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for OOI
Latest FDA decisions
- Revogene510(k)
K243922 · Decided Mar 20, 2025 · 90 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
- Revogene510(k)
K222779 · Decided Jan 26, 2023 · 134 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
- Revogene510(k)
K220480 · Decided Jul 11, 2022 · 143 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
- revogene510(k)
K170558 · Decided May 25, 2017 · 90 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
K161495 · Decided Jun 30, 2016 · 29 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
- ARIES System510(k)
K160517 · Decided Apr 12, 2016 · 48 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
- ARIES System510(k)
K151917 · Decided Oct 6, 2015 · 85 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
K151690 · Decided Jul 16, 2015 · 23 days after receipt
Device type: Real Time Nucleic Acid Amplification System (OOI) · Laboratory Medicine & Pathology
Reports received
516
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
510
99% of reports
Injury reports
6
1.2% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 18 | 0 | 0 | 0 |
| Jan 24 | 18 | 0 | 0 | 0 |
| Feb 24 | 14 | 0 | 0 | 0 |
| Mar 24 | 20 | 0 | 0 | 0 |
| Apr 24 | 11 | 1 | 0 | 0 |
| May 24 | 23 | 0 | 0 | 0 |
| Jun 24 | 34 | 0 | 0 | 0 |
| Jul 24 | 13 | 1 | 0 | 0 |
| Aug 24 | 21 | 1 | 0 | 0 |
| Sep 24 | 20 | 0 | 0 | 0 |
| Oct 24 | 28 | 0 | 0 | 0 |
| Nov 24 | 42 | 0 | 0 | 0 |
| Dec 24 | 81 | 0 | 0 | 0 |
| Jan 25 | 58 | 0 | 0 | 0 |
| Feb 25 | 25 | 0 | 0 | 0 |
| Mar 25 | 31 | 2 | 0 | 0 |
| Apr 25 | 27 | 0 | 0 | 0 |
| May 25 | 26 | 0 | 0 | 0 |
| Jun 25 | 65 | 1 | 0 | 0 |
| Jul 25 | 34 | 1 | 0 | 0 |
| Aug 25 | 45 | 1 | 0 | 0 |
| Sep 25 | 40 | 2 | 0 | 0 |
| Oct 25 | 78 | 0 | 0 | 0 |
| Nov 25 | 44 | 0 | 0 | 0 |
| Dec 25 | 53 | 0 | 0 | 0 |
| Jan 26 | 19 | 0 | 0 | 0 |
| Feb 26 | 71 | 0 | 0 | 0 |
| Mar 26 | 33 | 1 | 0 | 0 |
| Apr 26 | 55 | 0 | 0 | 0 |
| May 26 | 59 | 0 | 0 | 0 |
| Jun 26 | 32 | 0 | 0 | 0 |
| Jul 26 | 43 | 0 | 0 | 0 |
| Aug 26 | 33 | 1 | 0 | 0 |
| Sep 26 | 35 | 1 | 0 | 0 |
| Oct 26 | 33 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott84
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Positive Result340
- False Negative Result50
- Fluid/Blood Leak49
- Incorrect, Inadequate or Imprecise Result or Readings28
- Unable to Obtain Readings9
- Structural Problem7
- Break6
- Defective Device6
- Mechanical Problem5
- Fumes or Vapors3
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions510
- Eye Irritation4
- Headache1
- Insufficient Information1
- Skin Tears1
- Sore Throat1
- Upper Respiratory Tract Irritation1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1665-2025 · Started Mar 20, 2025 · Posted by FDA Apr 24, 2025
Reason given: The design of the Alinity m System Solutions drawer enclosure may allow liquid (liquid waste or system solutions) originating in the System Solutions drawer to flow beyond the footprint of the instrument and into the walking-path of the user.
Cause as FDA categorized it: Device Design
Z-0836-2025 · Started Dec 10, 2024 · Posted by FDA Jan 10, 2025
Reason given: False-positive MSI-H results generated by the Idylla MSI Test.
Cause as FDA categorized it: Environmental control
- Alinity m System, Part Number: 08N53-002Open, Classified
Z-1602-2024 · Started Mar 20, 2024 · Posted by FDA Apr 19, 2024
Reason given: The Alinity m System camera detects whether tubes are "capped." If the camera detects a cap and the retention bar is not present on the sample rack, the system will generate the message 'Error - 6013: Has cap, no retention bar." Abbott has identified an issue concerning the use of certain third-party Universal...
Cause as FDA categorized it: Under Investigation by firm
- Wash station: M1000 Wash Station Assembly & DITI Slide, REF 04J72-28* (*This part number is a spare to the M2000sp.)Open, Classified
Z-1190-2024 · Started Feb 1, 2024 · Posted by FDA Feb 26, 2024
Reason given: Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.
Cause as FDA categorized it: Process control
Z-0782-2024 · Started Dec 15, 2023 · Posted by FDA Jan 23, 2024
Reason given: Due to potential false positive Flu B results when a sample was also SARS-CoV-2 positive.
Cause as FDA categorized it: Under Investigation by firm
Z-2153-2023 · Started Jun 14, 2023 · Posted by FDA Jul 18, 2023
Reason given: There is a potential for the direct amplification disc to malfunction which may result in spillage of liquid from the disc.
Cause as FDA categorized it: Under Investigation by firm
Z-1009-2023 · Started Dec 9, 2022 · Posted by FDA Jan 20, 2023
Reason given: The firm identified the following three potential issues which may have impacted ADUs installed on distributed Alinity m Systems. 1. Systems which had their ADUs serviced may have an incorrect board value (calibration data file) referenced causing a misconfiguration of the calibration. 2. Inability of Maintenance and...
Cause as FDA categorized it: Under Investigation by firm
- Abbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4.Open, Classified
Z-1349-2023 · Started Nov 11, 2022 · Posted by FDA Apr 6, 2023
Reason given: The instrument was found to be installed without plunger assemblies in the clamp bar for an Amplification Detection Unit. After correction of the issue, the instrument was returned for use without calibration. This would result in a potential for delay of results and incorrect results.
Cause as FDA categorized it: Under Investigation by firm
Showing the 8 newest of 30 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.